Vaxart, Inc. (VXRT) News Headlines

▮ More

Date

Headline

9/1/2022 8:10:08 AM Vaxart: Phase II Study Of Wuhan S-only Oral Pill COVID-19 Vaccine Candidate Meets Endpoints

9/1/2022 7:43:34 AM Vaxart Announces Positive Top-line Data From Phase II Study Of Wuhan S-Only COVID-19 Pill Vaccine Candidate

5/2/2022 7:28:39 AM Pre-market Movers: SOUN, BIOL, QMCO, FATH, VXRT…

10/8/2021 6:51:18 AM Pre-market Movers: MIC, ALLO, EFTR, CEI, SNDL…

10/7/2021 5:34:04 PM Vaxart Jumps 12% On Positive Data From Oral Covid-19 Vaccine Study

10/6/2021 8:25:25 AM Vaxart To Begin US Phase II Trial Of S-Only Vaccine Candidate - Quick Facts

10/6/2021 8:07:44 AM Vaxart?Begins Recruiting In Global Phase II COVID-19 Oral Tablet Vaccine Trial

8/2/2021 8:38:35 AM FDA OKs Vaxart's IND Application For S-Only Oral Tablet SARS-CoV-2 Vaccine Candidate - Quick Facts

7/29/2021 9:26:31 AM Vaxart's Booster Study Of Oral Norovirus Vaccine Yields Encouraging Immune Responses

7/7/2021 10:30:26 AM Vaxart Rises 3% After Signing License Agreement With Altesa Biosciences

4/22/2021 9:58:50 AM Had It Been Covid-19 Oral Pill, More Americans Would Have Opted For Vaccination: Poll

2/4/2021 3:39:35 AM BIIB Pulls Plug On Parkinson's Drug, JAZZ Acquires GWPH, NBIX Ends Deal With VYGR, TYME Flies

2/3/2021 12:41:37 AM SAVA Jumps From $7 To $75 In Just 3 Weeks, DRRX Gets FDA Nod, IMVT Pauses Trials, OCGN Catches Eye

1/27/2021 2:56:46 AM AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch

1/26/2021 1:28:43 AM AZN Rejects Media Reports, MRK Quits COVID-19 Vaccine Work, MRNA Sets Eyes On New SARS-CoV-2 Strains

12/22/2015 8:35:31 AM FBR Capital Markets Starts Biota Pharmaceuticals Inc. (BOTA) At Outperform With $6 Price Target

Older Articles